Advertisement

Topics

Alvogen Inc. Company Profile

02:52 EDT 26th September 2018 | BioPortfolio

Alvogen is a multinational, privately-owned pharmaceuticals company, focused on developing, manufacturing and distributing generic, brand, over-the-counter brands (OTC) and biosimilar products. With more than 200 pharmaceutical projects in development and registration, the group’s product portfolio consists of a broad range of leading molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory, neurology and gastroenterology. Alvogen has commercial operations in over 30 countries with 1,900 employees. Alvogen welcomes inquiries regarding partnering opportunities. Please contact Alexander Mironov, Vice President, Business Development, at +1.973.487.3951 for more information.


News Articles [20 Associated News Articles listed on BioPortfolio]

Alvogen Obtains European Approvals for Generic Lenalidomide

Alvogen today announced that it has successfully concluded multiple registration procedures for Lenalidomide capsules. Alvogen received regulatory clearance for its product in sev...

Prestige Biopharma And Alvogen Announce License And Supply Agreement To Commercialize Biosimilar

NewsPrestige BioPharma and Alvogen have entered into a binding agreement for the exclusive partnership and supply for the commercialization of Prestige BioPharma´s Trastuzumab biosimilar in Central a...

US prison ‘fraudulently’ obtained sedative for lethal injection, claims Alvogen

Alvogen has won a court order preventing the Nevada Department of Corrections from using its sedative drug product, midazolam, in an execution.

Alvogen receives European approval for generic lenalidomide

US generics company Alvogen announced on 24 April 2018 that it had successfully concluded multiple registration procedures for its lenalidomide generic capsules.

Indivior rocked by loss of patent case

Indivior has been dealt a hammer blow after US District Court for the District of Delaware found in favour of Alvogen over claims of patent infringement. The case relates to Indivior’s lead product,...

Alvogen court case causes Nevada Judge to halt execution

A Nevada Judge has temporarily prevented the use of the sedative midazolam, in the execution of the twice convicted killer Scott Raymond Dozier, following objections from the New Jersey-based multinat...

Cadila scores FDA approval for BMS and Alvogen generics

Cadila Healthcare has announced that it has gained FDA final approval to market nifedipine ER tablets in the strengths of 30/60/90mg. The India-based company will manufacture nifedipine ER, a generic ...

Changchun High & New Forms $200 Million Biosimilar JV with Alvotech of Iceland

Changchun High & New Technology formed a $200 million China biosimilar JV with Alvotech, an Icelandic biotech. Changchun will fund the JV with $100 million while Alvotech will contribute $10 milli...

PubMed Articles [0 Results]

None

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

IO102 With Pembrolizumab, With or Without Chemotherapy, as First-line Treatment of Metastatic NSCLC

The purpose of this study is to determine if IO102 combined with pembrolizumab with or without chemotherapy is safe tolerable and effective in the treatment of Non-small Cell Lung Carcinom...

A Multi-Site Study Comparing Estradiol Vaginal Cream (0.01%) to Estrace® Cream (0.01%) in Postmenopausal Females With Atrophic Vaginitis

The purpose of this study is to determine the therapeutic equivalence of Alvogen's estradiol vaginal cream to Estrace® cream and superiority of both products to placebo. The protocol desc...

Companies [4 Associated Companies listed on BioPortfolio]

Alvogen Inc.

Alvogen is a multinational, privately-owned pharmaceuticals company, focused on developing, manufacturing and distributing generic, brand, over-the-counter brands (OTC) and biosim...

Alvogen Pharma US, Inc.

Alvogen is a multinational, privately-owned pharmaceuticals company, focused on developing, manufacturing and distributing generic, brand, over-the-counter brands (OTC) and biosim...

Alvogen, Inc. Alvogen, Inc.

Alvogen is a multinational pharmaceuticals company focused on complex generic products. Alvogen is committed to build the next-generation generics company through the strategic se...

Alvogen, Inc.

Alvogen is a multinational pharmaceuticals company focused on complex generic products. Alvogen is committed to build the next-generation generics company through the strategic se...

More Information about "Alvogen Inc." on BioPortfolio

We have published hundreds of Alvogen Inc. news stories on BioPortfolio along with dozens of Alvogen Inc. Clinical Trials and PubMed Articles about Alvogen Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alvogen Inc. Companies in our database. You can also find out about relevant Alvogen Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record